The Secret of Antibiofilm Agent for Burn Injury : A Systematic Review

Authors

  • Gembong Satria Mahardhika Faculty of Medicine. Universitas Jenderal Soedirman
  • Prahapsari Rupadha Faculty of Medicine, Universitas Muhammadiyah Purwokerto
  • Maudy Surya Pradisa Faculty of Medicine, Universitas Muhammadiyah Purwokerto

DOI:

https://doi.org/10.30595/hmj.v6i2.20464

Keywords:

Biofilm formation, Burn treatment, Burn wound, Septicemia

Abstract

Burn injuries remain to be a significant issue. The environmental condition in Indonesia contributes to the prevalence of diverse bacterial infection associated with different types of wounds, including burns. The biofilms production at the site of burn wounds significantly contributes to the ineffectiveness of burn treatment protocols. Hereby in this paper we discuss about the mechanism of antibiofilm and the novel therapy for the burn injury.  This study was classified as a systematic review approach. The compilation of references will be derived from journal articles obtained using search engines such as PubMed, Google Scholar, and EBSCO. Subsequently, the authors proceed to gather and reevaluate pertinent material and scholarly articles. The occurrence of biofilm is closely associated with burn injuries. These bacterial communities evoke antibiotic resistance, hence impeding the effectiveness of conventional treatment approaches. It is noteworthy that substantially 60% of burn-related mortality is attributed to biofilms. This condition has the potential to develop into a persistent wound, ultimately resulting in sepsis. The development of biofilm or invasive burn wound infection serves as a significant catalyst for the occurrence of sepsis. The administration of anti-biofilm drugs holds significant potential in this context as a proactive measure for reducing the worsening effects of burns. 

Conclusion : The utilization of anti-biofilm agents has the potential to serve as an innovative therapeutic approach for the treatment of burn wounds in the future. Further investigation is required to explore the potential outcome as well as adverse effects of this drug linked to its potency.

References

1. El Hamzaoui N, Barguigua A, Larouz S, Maouloua M. Epidemiology of burn wound bacterial infections at a Meknes hospital, Morocco. New Microbes New Infect. 2020;38:100764. doi:10.1016/j.nmni.2020.100764

2. Thomas RE, Thomas BC. Reducing Biofilm Infections in Burn Patients’ Wounds and Biofilms on Surfaces in Hospitals, Medical Facilities and Medical Equipment to Improve Burn Care: A Systematic Review. Int J Environ Res Public Health. 2021;18(24):13195. doi:10.3390/ijerph182413195

3. Maslova E, Eisaiankhongi L, Sjöberg F, McCarthy RR. Burns and biofilms: priority pathogens and in vivo models. Npj Biofilms Microbiomes. 2021;7(1):73. doi:10.1038/s41522-021-00243-2

4. Tufanaru C, Munn Z, Aromataris E, Campbell J, Hopp L. Systematic reviews of effectiveness. Available from https://synthesismanual.jbi.global. Published online 2020. doi:https://doi.org/10.46658/JBIMES-20-04

5. Goodwine J, Gil J, Doiron A, et al. Pyruvate-depleting conditions induce biofilm dispersion and enhance the efficacy of antibiotics in killing biofilms in vitro and in vivo. Sci Rep. 2019;9(1):3763. doi:10.1038/s41598-019-40378-z

6. Flemming HC, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S. Biofilms: an emergent form of bacterial life. Nat Rev Microbiol. 2016;14(9):563-575. doi:10.1038/nrmicro.2016.94

7. Rumbaugh KP, Sauer K. Biofilm dispersion. Nat Rev Microbiol. 2020;18(10):571-586. doi:10.1038/s41579-020-0385-0

8. Ma Z, Han J, Chang B, et al. Membrane-Active Amphipathic Peptide WRL3 with in Vitro Antibiofilm Capability and in Vivo Efficacy in Treating Methicillin-Resistant Staphylococcus aureus Burn Wound Infections. ACS Infect Dis. 2017;3(11):820-832. doi:10.1021/acsinfecdis.7b00100

9. Lu M, Wang S, Wang T, et al. Bacteria-specific phototoxic reactions triggered by blue light and phytochemical carvacrol. Sci Transl Med. 2021;13(575):eaba3571. doi:10.1126/scitranslmed.aba3571

10. Regulski M, Myntti MF, James GA. Anti-Biofilm Efficacy of Commonly Used Wound Care Products in In Vitro Settings. Antibiotics. 2023;12(3):536. doi:10.3390/antibiotics12030536

11. Malone M, Bjarnsholt T, McBain AJ, et al. The prevalence of biofilms in chronic wounds: a systematic review and meta-analysis of published data. J Wound Care. 2017;26(1):20-25. doi:10.12968/jowc.2017.26.1.20

12. Kirketerp‐Møller K, Stewart PS, Bjarnsholt T. The zone model: A conceptual model for understanding the microenvironment of chronic wound infection. Wound Repair Regen. 2020;28(5):593-599. doi:10.1111/wrr.12841

13. Brandenburg KS, Weaver AJ, Karna SLR, Leung KP. The impact of simultaneous inoculation of Pseudomonas aeruginosa, Staphylococcus aureus, and Candida albicans on rodent burn wounds. Burns. 2021;47(8):1818-1832. doi:10.1016/j.burns.2021.02.025

14. Pallavali RR, Degati VL, Narala VR, Velpula KK, Yenugu S, Durbaka VRP. Lytic Bacteriophages Against Bacterial Biofilms Formed by Multidrug-Resistant Pseudomonas aeruginosa , Escherichia coli , Klebsiella pneumoniae , and Staphylococcus aureus Isolated from Burn Wounds. PHAGE. 2021;2(3):120-130. doi:10.1089/phage.2021.0004

15. Pourhajibagher M, Rahimi-esboei B, Ahmadi H, Bahador A. The anti-biofilm capability of nano-emodin-mediated sonodynamic therapy on multi-species biofilms produced by burn wound bacterial strains. Photodiagnosis Photodyn Ther. 2021;34:102288. doi:10.1016/j.pdpdt.2021.102288

16. Kamper SJ. Blinding: Linking Evidence to Practice. J Orthop Sports Phys Ther. 2018;48(10):825-826. doi:10.2519/jospt.2018.0705

Downloads

Additional Files

Published

2024-05-01

Issue

Vol. 6 No. 2 (2023): Herb-Medicine Journal October 2023

Section

Literature Review

License

For submission of manuscripts to the Herb-Medicine Journal, the authors must certify that:

I have been authorized by my co-author to submit the manuscript to the Herb-Medicine Journal
I hereby declare, on behalf of myself and my co-authors, that:

The submitted manuscript is original work and has not been published in another peer-reviewed journal or is being considered for publication by another journal. Also, the manuscript does not infringe any existing copyright or other third party rights.
The manuscript does not contain material that may violate the law, slander, or SARA, in any way, violates the terms and conditions contained in the agreement
I/we have taken care that the scientific knowledge and all other statements contained in the manuscript are in accordance with authentic facts and formulas and will not, if followed appropriately, harm the user
No liability shall be assumed by Herb-Medicine Journal, its staff or members of the editorial board for any injury and/or damage to persons or property as a matter of product liability, negligence or otherwise, or from the use or operation of any method, product instructions, advertising , or ideas contained in publications by the Herb-Medicine Journal

Authors who publish in the Herb-Medicine Journal certify that all authors have read and agree to the contents of the Cover Letter or the Terms and Conditions. Plagiarism is strictly prohibited, and by submitting a manuscript for publication, the author agrees that the publisher has the legal right to take appropriate action against the author, if plagiarism or false information is found. Once submitted to the Herb-Medicine Journal, authors will not withdraw their manuscript at any stage prior to publication.

The author owns the copyright and grants the journal rights for first publication with the work simultaneously licensed under a Creative Commons Attribution License which allows others to share the work with acknowledgment of the work's authorship and initial publication in this journal.

Authors may enter into separate additional contractual agreements for the non-exclusive distribution of the published journal version of the work (for example, posting it to an institutional repository or publishing it in a book), with acknowledgment of its initial publication in this journal.

Authors are permitted and encouraged to post their work online (for example, in institutional repositories or on their websites) prior to and during the submission process, as this can lead to productive exchanges, as well as earlier and larger citation of published work (See The Effects of Open Access).

Untuk pengiriman naskah ke Herb-Medicine Journal, penulis harus menyatakan bahwa:

  1. Saya telah diberikan otorisasi oleh rekan penulis saya untuk memasukkan naskah ke Herb-Medicine Journal
  2. Saya dengan ini menyatakan, atas nama saya dan rekan penulis saya, bahwa:
  • Naskah yang dikirimkan adalah karya asli dan belum pernah diterbitkan dalam jurnal peer-review lain atau sedang dipertimbangkan untuk diterbitkan oleh jurnal lain. Serta, naskah tidak melanggar hak cipta yang ada atau hak pihak ketiga lainnya.
  • Naskah tidak mengandung materi yang mungkin melanggar hukum, memfitnah, atau SARA, dengan cara apa pun, melanggar syarat dan ketentuan yang tercantum dalam perjanjian
  • Saya / kami telah berhati-hati bahwa pengetahuan ilmiah dan semua pernyataan lain yang terkandung dalam naskah sesuai dengan fakta dan formula otentik dan tidak akan, jika diikuti dengan tepat, merugikan pengguna
  • Tidak ada tanggung jawab yang ditanggung oleh Herb-Medicine Journal, stafnya atau anggota dewan editorial untuk setiap cedera dan/atau kerusakan pada orang atau properti sebagai masalah pertanggungjawaban produk, kelalaian atau sebaliknya, atau dari penggunaan atau pengoperasian metode, produk apa pun instruksi, iklan, atau ide yang terkandung dalam publikasi oleh Herb-Medicine Journal

Penulis yang menerbitkan dalam Herb-Medicine Journal menyatakan bahwa semua penulis telah membaca dan menyetujui isi Surat Pengantar atau Syarat dan Ketentuan. Plagiarisme dilarang keras, dan dengan menyerahkan naskah untuk publikasi, penulis setuju bahwa penerbit memiliki hak hukum untuk mengambil tindakan yang pantas terhadap penulis, jika ditemukan plagiarisme atau informasi palsu. Setelah diserahkan ke Herb-Medicine Journal, penulis tidak akan menarik naskah mereka pada tahap apa pun sebelum dipublikasikan.

Penulis memiliki hak cipta dan memberikan hak jurnal untuk publikasi pertama dengan karya yang secara simultan dilisensikan di bawah Lisensi Creative Commons Attribution yang memungkinkan orang lain untuk berbagi karya dengan pengakuan kepengarangan karya dan publikasi awal dalam jurnal ini.

Penulis dapat membuat perjanjian kontrak tambahan yang terpisah untuk distribusi non-eksklusif versi jurnal yang diterbitkan dari karya tersebut (misalnya, mempostingnya ke repositori institusional atau menerbitkannya dalam sebuah buku), dengan pengakuan atas publikasi awalnya di jurnal ini.

Penulis diizinkan dan didorong untuk memposting pekerjaan mereka secara online (misalnya, dalam repositori institusional atau di situs web mereka) sebelum dan selama proses pengajuan, karena dapat menyebabkan pertukaran yang produktif, serta kutipan yang lebih awal dan lebih besar dari karya yang diterbitkan (Lihat The Effect of Open Access).